In conclusion, we found that levels of TLR10 were increased in CD27−IgD− and CD19+CD5+ B cells in RA subjects and were positively correlated with disease activity, revealing that TLR10 as an immunosuppressive factor may play a critical role in the progression of RA. This evidence concerns the gene CD5 and rheumatoid arthritis.